Crossmark

The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type

Published Online: 2021-04-09

Published Print: 2021-12

Authors

Amin, Saber

Baine, Michael

Meza, Jane

Lin, Chi http://orcid.org/0000-0002-7279-0473
License Information

Text and Data Mining valid from 2021-04-09

Version of Record valid from 2021-04-09
More Information

Article History

Received: 22 September 2020

Accepted: 30 March 2021

First Online: 9 April 2021

Declarations

:

: This study used data from the NCDB. The data is de-identified and holds no identifying patient information, and therefore, written informed consent was not needed for this study. The institutional review board (IRB) was also not required for the study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current